Enteric Disease Testing Market To Reach $4.74 Billion By 2030

Enteric Disease Testing Market Growth & Trends

The global enteric disease testing market size is anticipated to reach USD 4.74 billion by 2030 and is anticipated to expand at a CAGR of 3.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing incidence of enteric diseases and the rising adoption of advanced diagnostic technologies are the major factors contributing to market growth. According to the U.S. Center for Disease Control and Prevention, nearly 11 and 21 million cases of typhoid fever and approximately 5 million paratyphoid fever cases are recorded worldwide each year.

The increasing incidence of gastrointestinal infections in multiple regions, driven by changing lifestyles and consumer preferences, has generated greater demand for enteric disease testing solutions. Growing awareness regarding the severe effects of enteric diseases, if not intervened in time, has led to the rising number of tests. The focus of multiple government agencies on protecting public health and preventing outbreaks is also expected to drive the growth of this industry in the coming years.

Government initiatives for improved healthcare, including screening programs, awareness campaigns, and specific welfare schemes, are projected to fuel market growth. For instance, in the U.S., the Centers for Disease Control and Prevention (CDC) uses the System for Enteric Disease Response, Investigation, and Coordination (SEDRIC) to ensure efficient surveillance and response to disease outbreaks linked to food or animal contact. It also helps manage the BEAM (Bacteria, Enterics, Ameba, and Mycotics) Dashboard, which provides enteric disease outbreak data to public viewers. Such initiatives are expected to result in increased testing in the forecast period.

 Request a free sample copy or view report summary: Enteric Disease Testing Market Report

Enteric Disease Testing Market Report Highlights

• The bacterial segment dominated the enteric disease testing market with nearly 60% share in 2024 owing to many bacteria, such as C. difficile, E. coli, Shigella, and Salmonella, which cause common enteric diseases.

• The parasitic segment is expected to experience growth due to increasing cases of enteric diseases driven by contaminated water and food, poor sanitation systems in various regions, and lack of adequate hygiene.

• The growing focus of multiple governments on offering improved healthcare services that feature advanced diagnostic technologies to prevent large-scale outbreaks is expected to create growth opportunities.

• North America dominated the global industry in 2024 owing to factors such as a robust healthcare infrastructure and the presence of key diagnostic technology developers and biotechnology companies.

• Preventive measures embraced by local agencies and government-funded research programs are anticipated to fuel growth.

• In February 2025, BIOMÉRIEUX announced that it received clearance from the U.S. FDA for its new testing solution, BIOFIRE FILMARRAY Gastrointestinal (GI) Panel Mid.

Enteric Disease Testing Market Segmentation

Grand View Research has segmented the enteric disease testing market on the basis of disease and region:

Enteric Disease Testing Disease Outlook (Revenue, USD Million; 2018 - 2030)

• Bacterial

  • C. Difficile

  • Campylobacteriosis

  • Cholera

  • E.Coli

  • H.Pylori

  • Salmonellosis

  • Shigellosis

• Viral

  • Rotavirus

  • Norovirus

• Parasitic

  • Amebiasis

  • Cryptosporidiosis

  • Giardiasis

Enteric Disease Testing Region Outlook (Revenue, USD Million; 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Thailand

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Enteric Disease Testing Market

• Abbott

• BD

• Biomerica

• BIOMÉRIEUX

• Bio-Rad Laboratories, Inc.

• Cepheid

• Coris BioConcept

• DiaSorin S.p.A.

• Meridian Bioscience

• Quest Diagnostics Incorporated.